Exicure, Inc.
General ticker "XCUR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $59.2M (TTM average)
Exicure, Inc. does not follow the US Stock Market performance with the rate: -32.0%.
Estimated limits based on current volatility of 9.3%: low 5.07$, high 6.11$
Factors to consider:
- Total employees count: 7 (+16.7%) as of 2024
- Top business risk factors: Insufficient funding, Leadership changes, Management stability, Cybersecurity threats, Facility disruptions
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.04$, 21.02$]
- 2025-12-31 to 2026-12-31 estimated range: [3.93$, 11.80$]
Short-term XCUR quotes
Long-term XCUR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $28.83MM | $0.00MM | $0.50MM |
| Operating Expenses | $30.66MM | $15.00MM | $12.73MM |
| Operating Income | $-1.83MM | $-15.00MM | $-12.23MM |
| Non-Operating Income | $-0.54MM | $-1.92MM | $2.54MM |
| Interest Expense | $0.59MM | $0.00MM | $0.02MM |
| R&D Expense | $19.77MM | $1.42MM | $0.00MM |
| Income(Loss) | $-2.37MM | $-16.91MM | $-9.69MM |
| Taxes | $0.21MM | $0.00MM | $0.01MM |
| Profit(Loss)* | $-2.58MM | $-16.91MM | $-9.70MM |
| Stockholders Equity | $14.92MM | $3.03MM | $6.77MM |
| Assets | $23.33MM | $11.58MM | $15.06MM |
| Operating Cash Flow | $-35.66MM | $-10.36MM | $-2.91MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $4.70MM | $-1.08MM | $0.00MM |
| Financing Cash Flow | $-3.10MM | $3.67MM | $13.40MM |
| Earnings Per Share** | $-0.56 | $-2.11 | $-1.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.